A critical advance in cancer study is occurring with the use of nanobodies to re-engage mutated p53. This crucial tumor protector protein is frequently disabled in many forms of malignancies, leading uncontrolled https://ztndz.com/story29823244/mini-antibodies-revive-the-p53-protein-a-new-pathway-for-malignant-management